delavirdine has been researched along with epoxomicin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Danis, M; Derouin, F; Farhati, K; Franetich, JF; Galvez, J; Garcia-Domenech, R; Hannoun, L; Mahmoudi, N; Mazier, D; Sauerwein, R | 1 |
| Lopes, F; Moreira, R; Mota, MM; Prudêncio, M; Rodrigues, T | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 review(s) available for delavirdine and epoxomicin
| Article | Year |
|---|---|
Targeting the liver stage of malaria parasites: a yet unmet goal.
Topics: Animals; Antimalarials; Humans; Life Cycle Stages; Liver; Malaria; Plasmodium; Structure-Activity Relationship | 2012 |
2 other study(ies) available for delavirdine and epoxomicin
| Article | Year |
|---|---|
New active drugs against liver stages of Plasmodium predicted by molecular topology.
Topics: Animals; Antimalarials; Hepatocytes; Humans; Liver; Mice; Models, Biological; Parasitic Sensitivity Tests; Plasmodium yoelii; Structure-Activity Relationship | 2008 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |